Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Sunita Patruni"'
Publikováno v:
JCO oncology practice.
Recent data support incorporation of immune checkpoint inhibitors into the treatment armamentarium for esophageal, gastroesophageal junction, and gastric (esophagogastric) cancer. This practical review focuses on clinical trials that influenced US Fo
Publikováno v:
Journal of Clinical Oncology. 41:665-665
665 Background: Germline genetic testing is recommended for patients with pancreatic ductal adenocarcinoma (PDAC) and pre-diagnostic testing is offered to patients with a significant family history. However, only 36% of patients in our institution ob
Autor:
Dylan Cooper, Baho Sidiqi, Ruwan Parakrama, Lyudmyla Demyan, Shamsher Pasha, Danielle Pinto, Tiffany Zavadsky, Xianghui Zou, Sunita Patruni, Adrianna Kapusta, Oliver Standring, Jason Nosrati, Leila T Tchelebi, Matthew John Weiss, Joseph M. Herman, Daniel King
Publikováno v:
Journal of Clinical Oncology. 41:695-695
695 Background: Significant variation exists in the management of potentially resectable pancreatic ductal adenocarcinoma (PDAC) across healthcare systems. We describe the results of a newly implemented neoadjuvant therapy pathway (NATP) in New York
Autor:
Ruwan Parakrama, Baho Sidiqi, Lyudmyla Demyan, Shamsher Pasha, Danielle Pinto, Tiffany Zavadsky, Xianghui Zhou, Sunita Patruni, Adrianna Kapusta, Oliver Standring, Matthew J. Weiss, Joseph M. Herman, Daniel A. King
Publikováno v:
Cancer Research. 82:A022-A022
Optimal management of patients with potentially resectable pancreatic ductal adenocarcinoma (PDAC) is controversial and variation exists within/across academic and healthcare systems. Herein we describe the initial results of a neoadjuvant therapy (N
Publikováno v:
Cancer Research. 82:PR001-PR001
Introduction: Germline genetic testing is now recommended for patients with pancreatic ductal adenocarcinoma (PDAC). We explored whether attributes of testing, such as uptake fraction and rate, were associated with various clinical features. Here we
Publikováno v:
Journal of Hematology
Atypical hemolytic uremic syndrome (aHUS) is a rare form of thrombotic microangiopathy (TMA) which generally presents as a triad of thrombocytopenia, hemolytic anemia and renal failure. We present the case of a 69-year-old woman with ongoing fevers,
Publikováno v:
Journal of Clinical Oncology. 40:e16233-e16233
e16233 Background: Germline genetic testing is now recommended for patients with pancreatic ductal adenocarcinoma (PDAC). We explored whether attributes of testing, such as uptake fraction and rate, were associated with various clinical features. Her
Autor:
Ahmed Khattab, Sunita Patruni, Vivek Verma, Gene Grant Finley, Ethan B. Ludmir, Stephen Abel, Rodney E. Wegner, Shaakir Hasan, Dulabh Monga
Publikováno v:
Journal of gastrointestinal oncology. 10(5)
Background: Response of pancreatic adenocarcinoma to neoadjuvant chemotherapy (nCT) or chemoradiotherapy (nCRT) may be associated with prognosis, but long-term outcomes based on response to neoadjuvant therapy have not been well evaluated to date. Me
Autor:
Ahmed Khattab, Sunita Patruni, Yesica Garciafigueroa, Brett Phillips, Carl Engman, Nazia Khatoon, Karthik Shankar, Ali Rizvi, Stacey Miller, Lei Zheng, Nick Giannoukakis, Dulabh K. Monga
Publikováno v:
Journal of Clinical Oncology. 39:e16271-e16271
e16271 Background: Obesity is an established risk factor for cancer and cancer-related mortality. Adipocytes may act as a “damage” signal resulting in the accumulation of innate immune cells, fueling an inflammatory micro-environment. Among the i
Publikováno v:
Mathews Journal of Gastroenterology & Hepatology. 4